Cisen Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Cisen Pharmaceutical has a total shareholder equity of CN¥5.9B and total debt of CN¥74.1M, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are CN¥7.5B and CN¥1.6B respectively. Cisen Pharmaceutical's EBIT is CN¥473.5M making its interest coverage ratio -6.5. It has cash and short-term investments of CN¥2.6B.
Key information
1.3%
Debt to equity ratio
CN¥74.06m
Debt
| Interest coverage ratio | -6.5x |
| Cash | CN¥2.55b |
| Equity | CN¥5.87b |
| Total liabilities | CN¥1.61b |
| Total assets | CN¥7.48b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603367's short term assets (CN¥4.8B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 603367's short term assets (CN¥4.8B) exceed its long term liabilities (CN¥101.7M).
Debt to Equity History and Analysis
Debt Level: 603367 has more cash than its total debt.
Reducing Debt: 603367's debt to equity ratio has increased from 0% to 1.3% over the past 5 years.
Debt Coverage: 603367's debt is well covered by operating cash flow (583.7%).
Interest Coverage: 603367 earns more interest than it pays, so coverage of interest payments is not a concern.